Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
3.100
+0.350 (12.73%)
At close: Nov 7, 2025, 4:00 PM EST
2.900
-0.200 (-6.45%)
After-hours: Nov 7, 2025, 4:25 PM EST
Rapid Micro Biosystems Market Cap
Rapid Micro Biosystems has a market cap or net worth of $137.05 million as of November 7, 2025. Its market cap has increased by 247.13% in one year.
Market Cap
137.05M
Enterprise Value
119.91M
1-Year Change
247.13%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since the IPO on July 15, 2021, Rapid Micro Biosystems's market cap has decreased from $799.07M to $137.05M, a decrease of -82.85%. That is a compound annual growth rate of -33.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 137.05M | 253.86% |
| Dec 31, 2024 | 38.73M | 23.41% |
| Dec 29, 2023 | 31.38M | -33.87% |
| Dec 30, 2022 | 47.45M | -89.21% |
| Dec 31, 2021 | 439.99M | -44.94% |
| Jul 15, 2021 | 799.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |